A volunteer, in the city on a temporary work assignment, immersed himself in the shelter and fell in love with two dogs.

The city of Chordia is an amalgamation of people with different backgrounds and personalities, but everyone you speak to shares a unified sentiment: They all love Smolder, a popular boy band that has ...

Is listening a more optimal way of learning than reading a book? Do audiobooks improve young learners’ reading comprehension ...

A conversation with the University of Sydney’s Stefan Volk about how to manage the varied and fluctuating energy levels on your team. Are you a morning type, a night owl, or somewhere in between? And ...

Ali Farokhmanesh talks about what he learned in Year 1 as a head coach, from "battle rhythm" to finding his style, tuning out noise and more.

After returning from a long absence Sunday and appearing to aggravate his surgically repaired groin area, the Knicks backup guard said he was just feeling discomfort from scar tissue breaking down. He ...

A new study reveals that alpha brain waves help the brain decide what belongs to your body. Faster rhythms allow the brain to match sight and touch more precisely, strengthening the feeling that a ...

CINCINNATI (WKRC) - What began as dizziness, fatigue and a racing heart for Dr. Douglas Flora escalated into something more serious while he was traveling for work — and ultimately led him to seek ...

Rhythm Pharmaceuticals (RYTM) added ~8% in the premarket on Friday after the U.S. Food and Drug Administration (FDA) approved a label expansion for its lead asset, setmelanotide, to allow its use in ...

Rhythm Pharmaceuticals is switching up the tempo for its melanocortin-4 receptor (MC4R) agonist Imcivree. After its initial approval more than five years ago to treat certain patients with ...

Small commercial customers can now access Rhythm’s 100% renewable electricity plans designed to help businesses take advantage of lower-cost energy periods. HOUSTON--(BUSINESS WIRE)--Rhythm Energy, a ...

Rhythm Pharmaceuticals delivered strong FY25 revenue growth, driven by global demand for IMCIVREE (setmelanotide), reaching $194.8 million, up 50% year-over-year. RYTM’s upcoming March 20th FDA PDUFA ...